Status:
RECRUITING
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
CareDx
Conditions:
Transplant; Complication, Rejection
Eligibility:
All Genders
18+ years
Brief Summary
This is a non-randomized, non-interventional, prospective pilot cohort study to monitor SPK patients post-transplant to determine if non-invasive measures using dd-cfDNA (Allosure) and AlloMap can ass...
Detailed Description
Currently, one the challenges of durable glucose management after pancreas transplantation is the ability to accurately and expediently diagnose early rejection to prevent unnecessary damage to the gr...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study
- Male or Female, aged 18 years or above
- SKP transplant recipients between 1 month and 3 years after transplantation
Exclusion
- Previous history of solid organ transplantation
- Pregnancy
Key Trial Info
Start Date :
July 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04855422
Start Date
July 14 2021
End Date
December 1 2026
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10461